Q2 2019 Oncternal Therapeutics Inc Earnings Call

NEW YORK, NY / ACCESSWIRE / May 30, 2019 / Juan Monteverde, founder and managing partner at Monteverde &Associates PC, a national securities firm headquartered at the Empire State Building in New York City announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York against GTx, Inc. (NASDAQ: GTXI) ("GTx" or the "Company") for shareholders who held GTx securities as of the record date on April 15, 2019 (the "Class Period"), and have been harmed by GTx's and its Board of Directors' (the "Board") alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") in connection with the merger of the Company with Oncternal Therapeutics, Inc. ("Oncternal"). Under the terms of the transaction, each share of Oncternal common stock will be converted into the right to receive approximately 0.5137 shares of GTx's common stock (the "Merger Consideration").

Q4 2019 Oncternal Therapeutics Inc Earnings Call

Q3 2019 Oncternal Therapeutics Inc Earnings Call

Q1 2020 Oncternal Therapeutics Inc Earnings Call